TY - JOUR
T1 - Cough-Specific Quality of Life Predicts Disease Progression Among Patients With Interstitial Lung Disease
T2 - Data From the Pulmonary Fibrosis Foundation Patient Registry
AU - Pulmonary Fibrosis Foundation
AU - Lee, Janet
AU - White, Emily
AU - Freiheit, Elizabeth
AU - Scholand, Mary Beth
AU - Strek, Mary E.
AU - Podolanczuk, Anna J.
AU - Patel, Nina M.
AU - Bascom, Rebecca
AU - Belloli, Elizabeth
AU - Bhatt, Nitin
AU - Bhorade, Sangeeta
AU - Case, Amy
AU - Castriotta, Richard
AU - Criner, Gerard
AU - Danoff, Sonye
AU - De Andrade, Joao
AU - Desai, Alpa
AU - Glassberg, Marilyn
AU - Glazer, Craig
AU - Gulati, Mridu
AU - Gupta, Nishant
AU - Hamblin, Mark
AU - Huie, Tristan
AU - Kaner, Robert
AU - Kass, Daniel
AU - Kim, Hyun
AU - Kreider, Maryl
AU - Lancaster, Lisa
AU - Lasky, Joseph
AU - Limper, Andrew
AU - Montesi, Sydney
AU - Mooney, Joshua
AU - Morrison, Lake
AU - Nambiar, Anoop
AU - Nathan, Steven
AU - Natt, Bhupinder
AU - Paul, Tessy
AU - Perez, Rafael
AU - Podolanczuk, Anna
AU - Raghu, Ganesh
AU - Shifren, Adrian
AU - Strek, Mary
AU - Todd, Nevins
AU - Walia, Rajat
AU - Weight, Stephen
AU - Whelan, Timothy
AU - Wolters, Paul
N1 - Publisher Copyright:
© 2022 American College of Chest Physicians
PY - 2022/9
Y1 - 2022/9
N2 - Background: Cough is a common symptom of interstitial lung disease (ILD) and negatively impacts health-related quality of life (QOL). Previous studies have shown that among patients with idiopathic pulmonary fibrosis, cough may predict progression of lung disease and perhaps even respiratory hospitalizations and mortality. Research Question: Does cough-specific QOL predict disease progression, respiratory hospitalization, lung transplantation, and death among patients with ILD? Study Design and Methods: We analyzed data from the Pulmonary Fibrosis Foundation Registry, which comprises a multicenter population of well-characterized patients with ILD. We first examined associations between patient factors and baseline scores on the Leicester Cough Questionnaire (LCQ), a cough-specific QOL tool, using a proportional odds model. Next, we examined associations between baseline LCQ scores and patient-centered clinical outcomes, as well as pulmonary function parameters, using a univariable and multivariable proportional hazards model that was adjusted for clinically relevant variables, including measures of disease severity. Results: One thousand four hundred forty-seven patients with ILD were included in our study. In the multivariable proportional odds model, we found that the following patient factors were associated with worse cough-specific QOL: younger age, diagnosis of “other ILD,” gastroesophageal reflux disease, and lower FVC % predicted. Multivariable Cox regression models, adjusting for several variables including baseline disease severity, showed that a 1-point decrease in LCQ score (indicating lower cough-specific QOL) was associated with a 6.5% higher risk of respiratory-related hospitalization (hazard ratio [HR], 1.065; 95% CI, 1.025-1.107), a 7.4% higher risk of death (HR, 1.074; 95% CI, 1.020-1.130), and an 8.7% higher risk of lung transplantation (HR, 1.087; 95% CI, 1.022-1.156). Interpretation: Among a large population of well-characterized patients with ILD, cough-specific QOL was associated independently with respiratory hospitalization, death, and lung transplantation.
AB - Background: Cough is a common symptom of interstitial lung disease (ILD) and negatively impacts health-related quality of life (QOL). Previous studies have shown that among patients with idiopathic pulmonary fibrosis, cough may predict progression of lung disease and perhaps even respiratory hospitalizations and mortality. Research Question: Does cough-specific QOL predict disease progression, respiratory hospitalization, lung transplantation, and death among patients with ILD? Study Design and Methods: We analyzed data from the Pulmonary Fibrosis Foundation Registry, which comprises a multicenter population of well-characterized patients with ILD. We first examined associations between patient factors and baseline scores on the Leicester Cough Questionnaire (LCQ), a cough-specific QOL tool, using a proportional odds model. Next, we examined associations between baseline LCQ scores and patient-centered clinical outcomes, as well as pulmonary function parameters, using a univariable and multivariable proportional hazards model that was adjusted for clinically relevant variables, including measures of disease severity. Results: One thousand four hundred forty-seven patients with ILD were included in our study. In the multivariable proportional odds model, we found that the following patient factors were associated with worse cough-specific QOL: younger age, diagnosis of “other ILD,” gastroesophageal reflux disease, and lower FVC % predicted. Multivariable Cox regression models, adjusting for several variables including baseline disease severity, showed that a 1-point decrease in LCQ score (indicating lower cough-specific QOL) was associated with a 6.5% higher risk of respiratory-related hospitalization (hazard ratio [HR], 1.065; 95% CI, 1.025-1.107), a 7.4% higher risk of death (HR, 1.074; 95% CI, 1.020-1.130), and an 8.7% higher risk of lung transplantation (HR, 1.087; 95% CI, 1.022-1.156). Interpretation: Among a large population of well-characterized patients with ILD, cough-specific QOL was associated independently with respiratory hospitalization, death, and lung transplantation.
KW - Leicester cough questionnaire
KW - cough
KW - disease progression
KW - health-related quality of life
KW - idiopathic pulmonary fibrosis
KW - interstitial lung disease
KW - mortality
UR - http://www.scopus.com/inward/record.url?scp=85136361918&partnerID=8YFLogxK
U2 - 10.1016/j.chest.2022.03.025
DO - 10.1016/j.chest.2022.03.025
M3 - Article
C2 - 35337809
AN - SCOPUS:85136361918
SN - 0012-3692
VL - 162
SP - 603
EP - 613
JO - CHEST
JF - CHEST
IS - 3
ER -